Live calcium and mitochondrial imaging in the enteric nervous system of Parkinson patients and controls
- University of Leuven, Belgium
- University Hospitals Leuven, Belgium
Figures
Figure 1
Schematic representation of the experimental strategy.
Gastroduodenoscopy was performed on clinically well-characterized PD patients and their healthy partners, and 8 biopsies of the duodenum were taken per subject. The submucous plexus was peeled away …
Figure 2
Ca2+signalling in submucous neurons in biopsies from PD patients and controls.
(A.) Representative examples calcium imaging (left) and posthoc immunohistochemical staining (right). A typical example of submucous ganglia (PD and control) loaded with Fluo-4 is shown (left) as …
-
Figure 2—source data 1
Calcium imaging % responders.
GraphPad file with the corresponding values and graphs of the % of responders from the calcium imaging for the different stimuli HighK+, DMPP and electrical field stimulation (panel B, top graphs).
- https://doi.org/10.7554/eLife.26850.005
-
Figure 2—source data 2
Calcium imaging amplitude.
GraphPad file with the corresponding values and graphs of the amplitude from the calcium imaging for the different stimuli HighK+, DMPP and electrical field stimulation. (panel B, lower graphs).
- https://doi.org/10.7554/eLife.26850.006
Figure 3 with 1 supplement
Mitochondrial membrane potential measurements in the submucous plexus of PD patients and controls.
(A.) Representative example of a TMRE injection in the submucous plexus of a control subject. A subset of mitochondria was selected to show the TMRE intensity differences (as color-coded) in …
-
Figure 3—source data 1
Mitochondrial membrane potential measurements.
GraphPad file with the corresponding values and graphs of the mitochondrial membrane potential measurements (panel B and E).
- https://doi.org/10.7554/eLife.26850.012
Figure 3—figure supplement 1
Mitochondrial TMRE destaining in the submucous plexus after addition of FCCP.
Representative graph showing the average intensity in arbitrary units (A.U.) of 16 mitochondria labeled with TMRE and imaged at 37°C before and after addition of 3 µM FCCP. The complete destaining …
Figure 4
Mitochondrial number and volume in the submucous plexus of PD patients and controls.
(A.) Representative example of a submucous plexus injected with TMRE for a control (left) and PD patient (right). The 3D mask drawn around the injected ganglion is shown in grey. The inside of this …
-
Figure 4—source data 1
Mitochondrial ratio.
GraphPad file with the corresponding values and graph of mitochondrial ratio measurements (panel B).
- https://doi.org/10.7554/eLife.26850.015
-
Figure 4—source data 2
Mitochondrial density.
GraphPad file with the corresponding values and graph of mitochondrial density measurements (panel C).
- https://doi.org/10.7554/eLife.26850.016
-
Figure 4—source data 3
Mitochondrial volume.
GraphPad file with the corresponding values and graph of mitochondrial volume measurements (panel D).
- https://doi.org/10.7554/eLife.26850.017
Figure 5
Quantification of neuron and ganglia numbers in the submucous plexus of PD patients and controls.
(A.) Representative immunofluorescent staining of submucous plexus of a control and PD patient stained for the pan-neuronal marker HuCD (green) and neuronal filament marker NF200 (Magenta). Bars: 50 …
-
Figure 5—source data 1
Number of neurons per ganglia.
GraphPad file with the corresponding values and graph of number of neurons per ganglia (panel B).
- https://doi.org/10.7554/eLife.26850.019
-
Figure 5—source data 2
Number of neurons per biopsy.
GraphPad file with the corresponding values and graph of number of neurons per biopsy (panel C).
- https://doi.org/10.7554/eLife.26850.020
-
Figure 5—source data 3
Number of ganglia per biopsy.
GraphPad file with the corresponding values and graph of number of neurons per biopsy (panel D).
- https://doi.org/10.7554/eLife.26850.021
Figure 6
α-synuclein staining in the submucous plexus of PD patients and controls.
Top and bottom rows show three single slice confocal and deconvolved images of a representative immunofluorescent staining in the submucous plexus of a control (top) and PD patient (bottom) stained …
Author response image 1
Representative TMRE volume detection in the submucosal plexus.
The first panel shows the typical volume detection (yellow) with additional spot detection (blue). The second picture is showing a color-coded image specific for sphericity. Within the white dotted …
Videos
Video 1
Calcium imaging in human submucous neurons.
This movie shows a representative recording of Fluo-4 intensity changes in 2 human submucous ganglia (the ganglion on the right holds 2, while the one the left contains 5 neurons) during high K+ …
Video 2
Mitochondrial imaging in the human submucous plexus.
TMRE-labeled mitochondria in a submucous ganglion of a control subject are shown as well as the selection of mitochondria that are color-coded for intensity (see also Figure 3A).
Video 3
Mitochondrial imaging in the human submucous plexus.
Movie of TMRE-labeled mitochondria in a submucous ganglion of a PD patient. The TMRE intensity variations over time are shown as well as the 3D mask (in green, appearing half way in the movie) that …
Video 4
Mitochondrial imaging in the human submucous plexus.
Movie of TMRE-labeled mitochondria in a submucous ganglion of a control subject, showing TMRE fluctuations, selection of the ganglionic volume (3D mask) and mitochondrial volume detection (yellow) …
Tables
Table 1
Demographic and clinical characterization of PD patients and controls Mean ± SD are shown with associated p-value (non-parametric Wilcoxon T-testa | Wilcoxson T-test b | Chi squared test c).
| Control subjects (n = 15) | PD patients (n = 15) | p-value | |
|---|---|---|---|
| Gender (M:F) | 4: 11 | 11: 4 | 0.01 (*) C |
| Age | 57.8 ± 2.6 (range: 44–76) | 58.9 ± 9.2 (range: 45–71) | 0.40 a |
| SCOPA total | 5.6 ± 2.7 (range: 2–10) | 12.3 ± 9.2 (range: 2–32) | 0.03 (*) a |
| SCOPA GI | 0.9 ± 0.80 (range: 0–2) | 2.7 ± 2.29 (range: 0–8) | 0.02 (*) b |
| Disease duration (years) | - | 7.8 ± 3.9 (range: 2–17) | |
| UPDRS III off (disease severity) | - | 23.3 ± 10.0 (range: 12–46) | |
| Age at onset (years) | - | 51.1 ± 9.4 (range: 36–69) | |
| Hoehn-Yahr (off) | - | 2 (IQR: 2–5) | |
| LED (mg) | - | 684.1 ± 388.5 (range: 205–1740) | |
| MMSE | - | 29.6 ± 0.9 |
-
(*indicates a statistical difference p<0.05). For Hoehn-Yahr scores, median and interquartile range are shown.
Additional files
-
Supplementary file 1
Clinical characteristics of individual PD patients.
Clinical data of individual PD patients. SCOPA total, *Patient six entered ‘not applicable’ for the 2 SCOPA items related to sexual function. Mean ± SD are shown. For Hoehn-Yahr scores, median and interquartile range are shown instead of average and SD.
- https://doi.org/10.7554/eLife.26850.023
-
Supplementary file 2
Correlation between Ca2+ imaging data and PD characteristics
Spearman R-values of correlations between Ca2+ imaging parameters and clinical characteristics of PD patients (gray shaded rows) and where applicable (age, SCOPA) of controls (white rows).
- https://doi.org/10.7554/eLife.26850.024
-
Supplementary file 3
Correlations between mitochondrial imaging data and PD characteristics
Spearman R-values of correlations between mitochondrial imaging parameters and clinical characteristics of PD patients (gray shaded rows) and where applicable (age, SCOPA) of controls (white rows).
- https://doi.org/10.7554/eLife.26850.025
-
Supplementary file 4
Correlations between immunohistochemical data and PD characteristics
Spearman R-values of immunofluorescent counting correlated with clinical characteristics of the PD patients (gray shaded rows) and where applicable (age, SCOPA) of controls (white rows).
- https://doi.org/10.7554/eLife.26850.026
